基于脑脊液中EGFR T790M耐药突变的检测，用奥希替尼治疗一名非小细胞肺癌患者。 - Suppr

Suppr

超能文献

Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid.

作者信息

Théoleyre Sandrine, Masson Ingrid, Herbreteau Guillaume, Vallée Audrey, Sénellart Hélène, Denis Marc G

机构信息

Nantes University Hospital & Integrated Center for Oncology, Nantes, France.

出版信息

Lung Cancer. 2017 Dec;114:111-112. doi: 10.1016/j.lungcan.2017.10.010. Epub 2017 Oct 28.

DOI:10.1016/j.lungcan.2017.10.010

PMID:29096978

Abstract

摘要

相似文献

Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid.基于脑脊液中EGFR T790M耐药突变的检测，用奥希替尼治疗一名非小细胞肺癌患者。

Lung Cancer. 2017 Dec;114:111-112. doi: 10.1016/j.lungcan.2017.10.010. Epub 2017 Oct 28.

Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.奥希替尼治疗1例无T790M突变的EGFR+非小细胞肺癌软脑膜转移患者的临床疗效分析

Ann Palliat Med. 2019 Nov;8(5):525-531. doi: 10.21037/apm.2019.10.13.

T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis.脑脊液中T790M表皮生长因子受体突变检测及奥希替尼对一名肺癌脑膜转移患者的疗效

J Thorac Oncol. 2017 Sep;12(9):e138-e139. doi: 10.1016/j.jtho.2017.04.022.

Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC.表皮生长因子受体（EGFR）Leu792位点的新型突变可能与晚期非小细胞肺癌对奥希替尼的获得性耐药相关。

J Thorac Oncol. 2017 Jun;12(6):e65-e68. doi: 10.1016/j.jtho.2016.12.024. Epub 2017 Jan 16.

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.奥希替尼治疗 EGFR 突变型非小细胞肺癌伴 EGFR 酪氨酸激酶抑制剂预处理性脑膜转移的疗效。

Target Oncol. 2018 Aug;13(4):501-507. doi: 10.1007/s11523-018-0581-2.

Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.曲美替尼克服了 EGFR 突变型肺癌脑膜转移模型中 KRAS-G12V 诱导的奥希替尼耐药。

Cancer Sci. 2021 Sep;112(9):3784-3795. doi: 10.1111/cas.15035. Epub 2021 Jul 22.

Osimertinib effective in EGFR T790M-positive lung cancer.奥希替尼对EGFR T790M阳性肺癌有效。

Lancet Oncol. 2017 Jan;18(1):e9. doi: 10.1016/S1470-2045(16)30654-4. Epub 2016 Dec 16.

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy.奥希替尼治疗原发性耐药导致小细胞肺癌转化：液体再活检T790M 检测问题。

Lung Cancer. 2018 Jan;115:21-27. doi: 10.1016/j.lungcan.2017.11.011. Epub 2017 Nov 13.

Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation.奥希替尼在一名伴有软脑膜转移和EGFR罕见S768I突变患者中的疗效。

Lung Cancer. 2020 May;143:95-96. doi: 10.1016/j.lungcan.2020.03.016. Epub 2020 Mar 18.

Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer.奥希替尼（AZD9291）与两名未经放疗的EGFR突变且T790M阳性的晚期非小细胞肺癌患者的中枢神经系统反应

Clin Drug Investig. 2016 Aug;36(8):683-6. doi: 10.1007/s40261-016-0411-1.

引用本文的文献

Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss.奥希替尼与经治的非小细胞肺癌软脑膜转移患者预后改善相关：一项系统评价和荟萃分析。

Heliyon. 2024 Apr 17;10(9):e29668. doi: 10.1016/j.heliyon.2024.e29668. eCollection 2024 May 15.

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.前瞻性评估两种用于转移性黑色素瘤分子检测的筛选方法：BRAF V600E 免疫组织化学检测和基于 NRAS-BRAF 全自动实时 PCR 检测的诊断性能。

PLoS One. 2019 Aug 15;14(8):e0221123. doi: 10.1371/journal.pone.0221123. eCollection 2019.

Circulating free tumor-derived DNA to detect mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study.循环游离肿瘤来源DNA检测晚期非小细胞肺癌患者的突变：ASSESS研究的法国亚组分析

J Thorac Dis. 2019 Apr;11(4):1370-1378. doi: 10.21037/jtd.2019.03.95.

Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives.非小细胞肺癌中的循环游离肿瘤DNA：临床应用与未来展望

J Thorac Dis. 2019 Jan;11(Suppl 1):S113-S126. doi: 10.21037/jtd.2018.12.18.

Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer.EGFR T790M 阳性非小细胞肺癌的治疗。

Target Oncol. 2018 Apr;13(2):141-156. doi: 10.1007/s11523-018-0554-5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验